Scarica l'app Stockscreener
14.04
1.20%
-0.17
Dopo l'orario di chiusura:
14.04
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ADPT Giù?
Forum
Previsione
Precedente Chiudi:
$14.21
Aprire:
$14.21
Volume 24 ore:
1.23M
Relative Volume:
0.64
Capitalizzazione di mercato:
$2.24B
Reddito:
$276.98M
Utile/perdita netta:
$-59.46M
Rapporto P/E:
-35.21
EPS:
-0.3987
Flusso di cassa netto:
$-48.95M
1 W Prestazione:
-1.20%
1M Prestazione:
+13.13%
6M Prestazione:
-16.92%
1 anno Prestazione:
+80.69%
Intervallo 1D:
$13.71
$14.30
Intervallo di 1 settimana:
$13.50
$14.55
Portata 52W:
$7.16
$20.76
Adaptive Biotechnologies Corp Stock (ADPT) Company Profile
Nome
Adaptive Biotechnologies Corp
Settore
Industria
Telefono
206-659-0067
Indirizzo
1165 EASTLAKE AVE E, SEATTLE, WA
Compare ADPT vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ADPT
Adaptive Biotechnologies Corp
|
14.04 | 2.27B | 276.98M | -59.46M | -48.95M | -0.3987 |
VRTX
Vertex Pharmaceuticals Inc
|
430.14 | 108.36B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
731.77 | 78.05B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
775.03 | 48.74B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
302.11 | 41.16B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
298.16 | 33.17B | 5.36B | 287.73M | 924.18M | 2.5229 |
Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-02 | Ripresa | Morgan Stanley | Equal-Weight |
| 2025-09-30 | Iniziato | Guggenheim | Buy |
| 2025-06-18 | Iniziato | Craig Hallum | Buy |
| 2025-03-21 | Aggiornamento | Goldman | Neutral → Buy |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2022-12-21 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-08-25 | Iniziato | Credit Suisse | Underperform |
| 2022-06-03 | Iniziato | Piper Sandler | Neutral |
| 2022-02-16 | Reiterato | BTIG Research | Buy |
| 2022-02-16 | Reiterato | BofA Securities | Buy |
| 2022-02-16 | Reiterato | Goldman | Neutral |
| 2022-02-16 | Reiterato | JP Morgan | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-03-03 | Downgrade | Goldman | Buy → Neutral |
| 2020-10-08 | Ripresa | BTIG Research | Buy |
| 2020-09-09 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-06-03 | Iniziato | Goldman | Buy |
| 2019-07-23 | Iniziato | BTIG Research | Buy |
| 2019-07-22 | Iniziato | BofA/Merrill | Buy |
| 2019-07-22 | Iniziato | Cowen | Outperform |
| 2019-07-22 | Iniziato | Goldman | Neutral |
| 2019-07-22 | Iniziato | Guggenheim | Buy |
| 2019-07-22 | Iniziato | William Blair | Outperform |
Mostra tutto
Adaptive Biotechnologies Corp Borsa (ADPT) Ultime notizie
Adaptive Biotechnologies' COO Is Running a Systematic Sell Program — Here's What It Means - AOL.com
Time To Buy? Stock Analysis: NIO, XPeng XPEV, Costco, Adaptive Biotechnologies ADPT, GE (JtamyA8uVU) - Fathom Journal
Adaptive Biotechnologies COO Julie Rubinstein sells $798k in stock By Investing.com - Investing.com Canada
Adaptive Biotechnologies COO Julie Rubinstein sells $798k in stock - Investing.com
Adaptive Biotechnologies (ADPT) president sells 57K shares, exercises options - Stock Titan
[ARS] Adaptive Biotechnologies Corp SEC Filing - Stock Titan
Adaptive Biotechnologies (NASDAQ: ADPT) 2026 proxy details and 2025 performance - Stock Titan
Adaptive Biotechnologies COO Julie Rubinstein sells $1.01m in stock By Investing.com - Investing.com India
Adaptive Biotechnologies COO Julie Rubinstein sells $1.01m in stock - Investing.com
Adaptive Biotechnologies (ADPT) COO sells shares, exercises options under 10b5-1 plan - Stock Titan
Should You Sell Adaptive Biotechnologies (ADPT) After Its President and COO Sold 57,000 Shares? - AOL.com
Julie Rubinstein Sells 57,180 Shares of Adaptive Biotechnologies - Intellectia AI
Adaptive Biotechnologies: Strong Sequencing, Weak Margin Of Safety (NASDAQ:ADPT) - Seeking Alpha
Should You Sell Adaptive Biotechnologies (ADPT) After Its President and COO Sold 57,000 Shares? - The Motley Fool
Is Adaptive Bio (ADPT) stock stronger than peers (Investor Interest) 2026-04-18Investment Signal Network - Cổng thông tin điện tử tỉnh Lào Cai
Adaptive Biotechnologies Hits Day Low of $13.37 Amid Price Pressure - Markets Mojo
Adaptive Biotechnologies president Rubinstein sells $826k in ADPT stock By Investing.com - Investing.com Australia
Adaptive Biotechnologies president Rubinstein sells $826k in ADPT stock - Investing.com
Adaptive Biotechnologies (ADPT) COO exercises options and sells 57,180 shares - Stock Titan
Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026 - The Manila Times
Adaptive Biotechnologies schedules May 5 webcast for Q1 2026 results - Stock Titan
Adaptive Biotechnologies getting closer to key technical measure - MSN
Adaptive Biotechnologies (ADPT) moves 5.8% higher: Will this strength last? - MSN
Adaptive Biotechnologies (ADPT) president Rubinstein sells $758k in stock By Investing.com - Investing.com Australia
Adaptive Biotechnologies (ADPT) president Rubinstein sells $758k in stock - Investing.com
Adaptive Biotechnologies (NASDAQ: ADPT) COO sells shares under 10b5-1 plan - Stock Titan
Robins, Adaptive Biotechnologies CSO, sells $148,500 in stock By Investing.com - Investing.com Australia
Insider Sell: Harlan Robins Sells Shares of Adaptive Biotechnologies Corp (ADPT) - GuruFocus
Adaptive Biotechnologies (ADPT) chief people officer sells $340k in stock By Investing.com - Investing.com India
Adaptive Biotechnologies (ADPT) chief people officer sells $340k in stock - Investing.com Australia
Robins, Adaptive Biotechnologies CSO, sells $148,500 in stock - Investing.com
Adaptive Biotechnologies (ADPT) officer sells shares after option exercise - Stock Titan
Adaptive Biotechnologies (NASDAQ: ADPT) CSO sells 10,000 shares under 10b5-1 plan - Stock Titan
Adaptive Biotechnologies Corp. Opens with a 9.41% Gain, Outperforming S&P 500 - Markets Mojo
Adaptive Biotechnologies Hits Day High with 8.24% Surge in Stock Price - Markets Mojo
Why Adaptive Biotechnologies Stock Is Sinking Today - TipRanks
Insider Sell: Chad Robins Sells 120,595 Shares of Adaptive Biote - GuruFocus
Adaptive Biotechnologies president Rubinstein sells $990k in ADPT stock By Investing.com - Investing.com India
Adaptive Biotechnologies CEO Robins sells $1.76m in ADPT stock By Investing.com - Investing.com Australia
Adaptive Biotechnologies president Rubinstein sells $990k in ADPT stock - Investing.com
[Form 4] Adaptive Biotechnologies Corp Insider Trading Activity - Stock Titan
ADPT COO Rubinstein sells shares, exercises options under 10b5-1 plan - Stock Titan
Adaptive Biotechnologies Corp Azioni (ADPT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.29%
0.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):